Get the Stockscreener App
39.45
0.23%
-0.09
After Hours:
39.51
0.06
+0.15%
Surmodics Inc stock is traded at $39.45, with a volume of 34,638.
It is down -0.23% in the last 24 hours and up +5.17% over the past month.
See More
Previous Close:
$39.54
Open:
$39.42
24h Volume:
34,638
Relative Volume:
0.32
Market Cap:
$549.28M
Revenue:
$138.20M
Net Income/Loss:
$5.52M
P/E Ratio:
-23.91
EPS:
-1.65
Net Cash Flow:
$9.86M
1W Performance:
+0.31%
1M Performance:
+5.17%
6M Performance:
-6.29%
1Y Performance:
+19.84%
1-Day Range:
$39.42
$39.58
1-Week Range:
$39.12
$39.78
52-Week Range:
$25.17
$42.44
Surmodics Inc Stock (SRDX) Company Profile
Name
Surmodics Inc
Sector
Industry
Phone
(952) 500-7000
Address
9924 W 74TH ST, EDEN PRAIRIE, MN
Compare SRDX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SRDX
Surmodics Inc
|
39.45 | 549.28M | 138.20M | 5.52M | 9.86M | 0.38 |
|
ABT
Abbott Laboratories
|
118.77 | 206.00B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
392.15 | 149.49B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
90.66 | 133.62B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
86.54 | 110.97B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.35 | 42.08B | 6.60B | 4.16B | 490.10M | 6.93 |
Surmodics Inc Stock (SRDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-13-23 | Upgrade | Needham | Hold → Buy |
| Feb-13-23 | Downgrade | Needham | Buy → Hold |
| Jul-23-20 | Upgrade | Needham | Hold → Buy |
| Dec-11-19 | Downgrade | Needham | Buy → Hold |
| Nov-01-19 | Downgrade | Lake Street | Buy → Hold |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Lake Street | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Feb-21-19 | Reiterated | Needham | Buy |
| May-16-18 | Reiterated | Needham | Buy |
| Mar-01-18 | Upgrade | Sidoti | Neutral → Buy |
| Feb-28-18 | Reiterated | Lake Street | Buy |
| Feb-28-18 | Initiated | Needham | Buy |
| Jul-14-17 | Initiated | Lake Street | Buy |
| Nov-21-16 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Oct-06-16 | Downgrade | Sidoti | Buy → Neutral |
| May-03-16 | Reiterated | Barrington Research | Outperform |
| Aug-06-15 | Reiterated | Barrington Research | Outperform |
| Mar-27-15 | Initiated | Dougherty & Company | Buy |
| Feb-25-14 | Initiated | Laidlaw | Buy |
| Aug-01-13 | Upgrade | Feltl & Co. | Buy → Strong Buy |
| Nov-12-12 | Reiterated | Barrington Research | Outperform |
View All
Surmodics Inc Stock (SRDX) Latest News
Q2 Earnings Estimate for Surmodics Issued By Zacks Research - MarketBeat
Insider Sell: Timothy Arens Sells 7,009 Shares of Surmodics Inc (SRDX) - GuruFocus.com
Zacks Research Brokers Lift Earnings Estimates for Surmodics - MarketBeat
SRDX (Surmodics) Cyclically Adjusted PS Ratio : 4.90 (As of Nov. 26, 2024) - GuruFocus.com
Principal Financial Group Inc. Purchases Shares of 30,696 Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Now Covered by StockNews.com - MarketBeat
SurModics Inc. Faces Legal Hurdles: Shareholder Lawsuits Threaten Merger and Financial Stability - Yahoo Finance
The Gory Details on SurModics's Double Miss - AOL
(SRDX) Long Term Investment Analysis - Stock Traders Daily
Surmodics Inc. (SRDX) reports earnings - Quartzy
Nashville InnoSurmodics adds to med-device portfolio with $39.9M acquisition of Vetex Medical - The Business Journals
Phocas Financial Corp. Invests $3.43 Million in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Coverage Initiated at StockNews.com - MarketBeat
Surmodics Q4 Earnings and Revenues Beat Estimates, Margin Down - MSN
SurModics (SRDX) is an Incredible Growth Stock: 3 Reasons Why - Yahoo Finance
Medical Device Coatings Market: Expected High CAGR with Key - openPR
Surmodics FY2026 EPS Forecast Lifted by Barrington Research - MarketBeat
Nisa Investment Advisors LLC Sells 67,336 Shares of Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Barrington Research Predicts Higher Earnings for Surmodics - MarketBeat
SurModics (SRDX) Reports Q4 Loss, Tops Revenue Estimates - MSN
48,591 Shares in Surmodics, Inc. (NASDAQ:SRDX) Bought by Olympiad Research LP - MarketBeat
Needham & Company LLC Reiterates "Hold" Rating for Surmodics (NASDAQ:SRDX) - MarketBeat
Surmodics revenue jumps 19% to USD 33.2M in Q4 2024 - Medical Buyer
Surmodics (NASDAQ:SRDX) Shares Cross Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
Surmodics Inc. Reports Q4 and FY 2024 Results - TipRanks
Morgan Stanley's Strategic Reduction in Surmodics Inc Holdings - GuruFocus.com
Surmodics reports Q4 EPS (13c), consensus (29c) - TipRanks
SurModics: Fiscal Q4 Earnings Snapshot - San Antonio Express-News
Surmodics Reports Fourth Quarter and Fiscal Year 2024 Financial Results - Business Wire
Surmodics, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended September 30, 2024 - Marketscreener.com
Surmodics reports high success in limb ischemia study By Investing.com - Investing.com Australia
Surmodics Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce™ Thrombectomy System - BioSpace
Surmodics reports high success in limb ischemia study - Investing.com India
When (SRDX) Moves Investors should Listen - Stock Traders Daily
Surmodics (NASDAQ:SRDX) Now Covered by Analysts at StockNews.com - MarketBeat
Medical Coatings Market to Grow by USD 5.07 Billion from 2024-2028, Driven by Geriatric Population Growth and AI-Redefining the Market LandscapeTechnavio - Yahoo Finance Australia
Surmodics, Inc. (NASDAQ:SRDX) Shares Sold by Millennium Management LLC - MarketBeat
Surmodics (NASDAQ:SRDX) Earns Hold Rating from Analysts at StockNews.com - MarketBeat
Surmodics, Inc. to Post FY2025 Earnings of $0.13 Per Share, Zacks Research Forecasts (NASDAQ:SRDX) - MarketBeat
AQR Capital Management LLC Reduces Holdings in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Trend Tracker for (SRDX) - Stock Traders Daily
Algert Global LLC Makes New $577,000 Investment in Surmodics, Inc. (NASDAQ:SRDX) - MarketBeat
Surmodics (NASDAQ:SRDX) Coverage Initiated by Analysts at StockNews.com - MarketBeat
SRDX Stock Down Despite FDA Clearance for Pounce XL System - MSN
Biocompatible Coating Market to Reach $41.4 Billion, Globally, by 2033 at 12% CAGR: Allied Market Research - GlobeNewswire Inc.
Surmodics Inc Stock (SRDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.73%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):